Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bravaccio

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Italian Journal of Pediatrics|July 28, 2019
Distribution and age of onset of psychopathological risk in a cohort of children with Down syndrome in developmental ageM Marino, I Scala, O Scicolone, et al.
European Journal of Endocrinology|July 31, 1999
Intellectual outcome at 12 years of age in congenital hypothyroidismM Salerno, R Militerni, S Di Maio, et al.
European Journal of Paediatric Dentistry|March 19, 2020
Autism spectrum disorders and oral health status: review of the literatureG F Ferrazzano, C Salerno, C Bravaccio, et al.
European Journal of Medical Genetics|February 20, 2025
Variability in autism spectrum phenotypes linked to heterozygous missense familial ANK2 mutationR Garotti, M Marino, M P Riccio, et al.
American Journal of Medical Genetics|February 25, 2000
Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samplesA M Persico, R Militerni, C Bravaccio, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 27, 2011
Developmental evolution in a patient with multiple acyl-coenzymeA dehydrogenase deficiency under pharmacological treatmentM Rosa, A Pascarella, G Parenti, et al.
The Pharmacogenomics Journal|July 19, 2017
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactionsC Rafaniello, M Sessa, F F Bernardi, et al.
Psychiatric Genetics|August 30, 2001
No association between the 4g/5G polymorphism of the plasminogen activator inhibitor-1 gene promoter and autistic disorderA M Persico, R Militerni, C Bravaccio, et al.
American Journal of Medical Genetics|December 20, 2000
Adenosine deaminase alleles and autistic disorder: case-control and family-based association studiesA M Persico, R Militerni, C Bravaccio, et al.
Molecular Psychiatry|August 23, 2002
Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic childrenA M Persico, T Pascucci, S Puglisi-Allegra, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Italian Journal of Pediatrics|July 28, 2019
Distribution and age of onset of psychopathological risk in a cohort of children with Down syndrome in developmental ageM Marino, I Scala, O Scicolone, et al.
European Journal of Endocrinology|July 31, 1999
Intellectual outcome at 12 years of age in congenital hypothyroidismM Salerno, R Militerni, S Di Maio, et al.
European Journal of Paediatric Dentistry|March 19, 2020
Autism spectrum disorders and oral health status: review of the literatureG F Ferrazzano, C Salerno, C Bravaccio, et al.
European Journal of Medical Genetics|February 20, 2025
Variability in autism spectrum phenotypes linked to heterozygous missense familial ANK2 mutationR Garotti, M Marino, M P Riccio, et al.
American Journal of Medical Genetics|February 25, 2000
Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samplesA M Persico, R Militerni, C Bravaccio, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 27, 2011
Developmental evolution in a patient with multiple acyl-coenzymeA dehydrogenase deficiency under pharmacological treatmentM Rosa, A Pascarella, G Parenti, et al.
The Pharmacogenomics Journal|July 19, 2017
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactionsC Rafaniello, M Sessa, F F Bernardi, et al.
Psychiatric Genetics|August 30, 2001
No association between the 4g/5G polymorphism of the plasminogen activator inhibitor-1 gene promoter and autistic disorderA M Persico, R Militerni, C Bravaccio, et al.
American Journal of Medical Genetics|December 20, 2000
Adenosine deaminase alleles and autistic disorder: case-control and family-based association studiesA M Persico, R Militerni, C Bravaccio, et al.
Molecular Psychiatry|August 23, 2002
Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic childrenA M Persico, T Pascucci, S Puglisi-Allegra, et al.
Pageof 2